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CuI catalystA systematic study on the condensation reaction of 2,4-dichlorobenzo[h]quinoline and
naphth-1-ylamine in the presence of CuI as catalyst to functionalised mono- and di-substituted
(naphthalen-1-yl)benzo[h]quinoline amines was described. Subsequently these mono- and
di-substituted amines on polyphosphoric acid catalysed cyclisation reaction with aromatic/
heteroaromatic carboxylic acids led to the construction of angular and linear aromatic/
heteroaromatic substituted dinaphthonaphthyridines in good yields.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Cairo University.Introduction
In a quest to obtain lead molecules in the medicinal chemistry,
small molecules appended with differently substituted functional
groups can be of great interest, due to their potential to create a
number of chemical libraries. Among those, nitrogen containing
heterocycles such as quinolines and naphthyridines draw special
attention due to their wide variety of biological activities. For in-
stance, quinoline based chemical entities were known for their
anti-tuberculosis [1,2], antiproliferative [3,4], anthelmintic [5],antibacterial [6] and antioxidant activities [7]. 4-Amino-7-chloro-
quinoline derivatives and its modiﬁed side-chain analogs [8–10]
were representative class of antimalarial drugs. Extensive studies
were made to obtain biologically active quinolines and naph-
thyridine analogues starting from chloro quinolines [11]. The
synthesis of naphthyridines [12], benzonaphthyridines [13], and
dibenzonaphthyridines [14–16] from various starting precursors
were also well documented in the literature. Such naphthyridines
exhibit remarkable biological activities such as CB2 selective ago-
nists [17], anti-HIV [18], anticancer [19,20], selective 3-phospho-
inositide-dependent kinase-I inhibitors [21] and topoisomerase-I
inhibitors [22]. Naphthyridines were also explored as a versatile
ligand in the ﬁeld of inorganic chemistry [23].
Hence, there is a continuous urge to develop new methods
for the synthesis of naphthyridines. There are so many reports
in the literature about the utility CuI as catalyst. For
example, Buchwald explored CuI-catalysed coupling of
alkylamines and aryl iodides and also the N-arylation of sev-
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[24,25]. Recently CuI catalysts have been received good atten-
tion for N-arylation reaction between aryl halides and amines
[26,27], which in general are high yielding reactions under mild
conditions. It is also quite stable under open atmosphere, less
toxic and low cost. N-arylation of aromatic heterocycles and
amino acids catalysed by CuI catalyst under ligand free condi-
tions were recently reported [28]. These features encouraged
our interest in exploring the synthetic utility of CuI as a cata-
lyst for the synthesis of benzoquinoline amine intermediates
under ligand free condition.
To the best of our knowledge, there are no literature reports
for the synthesis of angular and linear aromatic/heteroaro-
matic substituted dinaphthonaphthyridines. Keeping the
importance of naphthyridine compounds in mind, here in we
report the synthesis of titled compounds by the reaction of
2,4-dichlorobenzo[h]quinoline via benzoquinolin-amine inter-
mediates utilising Bernthsen reaction condition. These func-
tionalised intermediates were prepared by simple amine-
halide condensation reaction between 1-naphthylamine and
2,4-dichlorobenzo[h]quinoline using CuI as catalyst.
Experimental
General
Melting points (Mp.) were determined on Mettler FP 51 appa-
ratus (Mettler Instruments, Switzerland) and were uncor-
rected. They were expressed in degree centigrade (C). A
Nicolet Avatar Model FT-IR spectrophotometer was used to
record the IR spectra (4000–400 cm1). 1H NMR and 13C
NMR spectra were recorded on Bruker AV 400 (400 MHz
(1H) and 100 MHz (13C)), Bruker AV 500 (500 MHz (1H)
and 125 MHz (13C)) spectrometer using tetramethylsilane
(TMS) as an internal reference. The chemical shifts were ex-
pressed in parts per million (ppm). Mass spectra (MS) were re-
corded on Auto Spec EI + Shimadzu QP 2010 PLUS GC–MS
mass spectrometer. Microanalyses were performed on a Vario
EL III model CHNS analyser (Vario, Germany) at the Depart-
ment of Chemistry, Bharathiar University, Coimbatore – 46,
India. The solvent and the reagents used (reagent grade) were
puriﬁed by standard methods. Anhydrous sodium sulphate
was used to dry the solution of organic extracts. Thin layer
chromatography (TLC) was performed using glass plates
coated with silica gel-G containing 13% calcium sulphate as
binder. Ethyl acetate and petroleum ether were used as devel-
oping solvents. A chamber containing iodine vapour was used
to locate the spots. Separation and puriﬁcation of the crude
products were carried out using chromatographic column
packed with activated silica gel (60–120 mesh). In the case of
mixture of solvents used for elution, the ratio of the mixture
is given in brackets.
Preparation of 2,4-dichlorobenzo[h]quinoline (3)
An equimolar mixture of naphth-1-ylamine (1, 0.01 mol),
malonic acid (2, 0.01 mol) and 40 mL of phosphorous oxychlo-
ride was reﬂuxed on water bath for 8 h and the reaction was
monitored by TLC. After the completion of the reaction, the
reaction mixture was poured into crushed ice and neutralised
with diluted solution of sodium hydroxide to give a whiteprecipitate, which was ﬁltered, dried and puriﬁed by silica col-
umn chromatography. The product was eluted with hexane, to
obtain 3 as a white solid; Mp.: 70–72 C; Yield: 45%; IR (KBr,
cm1) mmax: 1581 (C‚N);
1H NMR (400 MHz, CDCl3) (ppm)
dH: 7.62 (s, 1H, C3AH), 7.74–8.08 (m, 5H, C5, C6AC9AH),
9.22 (dd, 1H, Jo = 8.20 Hz, Jm = 1.20 Hz, C10AH); Anal.
Calcd. for C13H7Cl2N (247): C, 62.93; H, 2.84; N, 5.65%;
Found: C, 63.00; H, 2.78; N, 5.61%.
General procedure for the reaction of naphth-1-ylamine (1) with
2,4-dichlorobenzo[h] quinoline (3); preparation of 4-chloro-N-
(naphth-1-yl)benzo[h]quinolin-2-amine (4) and N2,N4-
di(naphth-1-yl)benzo[h]quinolin-2,4-diamine (5)
A mixture of 2,4-dichlorobenzo[h]quinoline (3, 0.010 mol),
naphth-1-ylamine (1, 0.010 mol) and CuI (10 mol%) was
heated in 20 mL of DMSO at 120 C for an hour. After the
completion of the reaction, water was added into the reaction
mixture. The resultant precipitate was washed with water,
dried and puriﬁed by column chromatography (neutral alu-
mina). Compound 4 was eluted with petroleum ether: ethyl
acetate (99:1) whereas compound 5 was eluted with ethyl ace-
tate: methanol (95:5). Both the compounds were recrystallised
using methanol.
4-Chloro-N-(naphth-1-yl)benzo[h]quinolin-2-amine (4)
White amorphous powder; Mp.: 126–128 C; Yield: 45%; IR
(KBr, cm1) mmax: 3066 (NH), 1636 (C‚N);
1H NMR
(500 MHz, CDCl3) (ppm) dH: 7.02 (s, 1H, C2ANH), 7.17
(s, 1H, C3AH), 7.54–7.84 (m, 8H, C8, C20AC80AH), 7.91 (t,
1H, J = 8.00 Hz, C9AH), 7.96 (d, 1H, J= 8.00 Hz,
C6AH), 8.01 (d, 1H, J= 8.50 Hz, C7AH), 8.15 (d, 1H,
J= 9.00 Hz, C5AH), 9.20 (dd, 1H, Jo = 8.00 Hz,
Jm = 1.50 Hz, C10AH);
13C NMR (125 MHz, CDCl3)
(ppm) dC: 109.17 (C3), 119.11 (C4a), 121.15 (C20), 121.25
(C4
0), 122.12 (C80), 124.50 (C50), 124.89 (C5), 125.95 (C70),
126.08 (C6
0), 126.50 (C30), 126.52 (C10), 126.59 (C6), 127.77
(C9), 128.38 (C8), 128.64 (C7), 129.34 (C8a
0), 130.22 (C4a0),
134.38 (C10a), 134.75 (C6a), 135.14 (C1
0), 143.75 (C10b),
147.06 (C4), 155.68 (C2); MS m/z (%) 354 (M+ H, 100),
356 (M+ 2, 31); Anal. Calcd. for C23H15ClN2 (354): C,
77.85; H, 4.26; N, 7.89%; Found: C, 77.79; H, 4.23; N,
7.82%.
N2,N4-Di(naphth-1-yl)benzo[h]quinolin-2,4-diamine (5)
Pale brown solid; Mp.:>300 C; Yield: 51%; IR (KBr, cm1)
mmax: 3136, 3054 (NH), 1629(C‚N);
1H NMR (500 MHz,
DMSO-d6) (ppm) dH: 6.51 (s, 1H, C3AH), 7.01–8.19 (m,
18H, C6AC9, C20AC80 & C20 0A, C800AH), 8.77 (d, 1H,
C5AH, J = 8.00 Hz), 9.38 (d, 1H, C10AH, J = 8.50 Hz),
10.74 (s, 1H, C4ANH), 11.45 (s, 1H, C2ANH), 14.13 (s,
1H, N1AH);
13C NMR (125 MHz, DMSO-d6) (ppm) dC:
86.26 116.36, 120.07, 121.05, 122.45, 122.82, 123.46, 125.16,
125.39, 126.30, 127.06 (2C), 127.20, 127.37, 128.27, 128.72,
128.95 (3C), 129.13, 129.32, 130.02, 132.35, 134.14, 134.34
(4C), 134.50, 134.88, 135.69, 152.88, 155.57; MS m/z (%)
462 (M+ H, 100); Anal. Calcd. for C33H23N3 (461): C,
85.87; H, 5.02; N, 9.10%; Found: C, 85.94; H, 4.99; N,
9.07%.
Synthesis of [1,6] and [1,8]dinaphthonaphthyridines 633General procedure for the synthesis of dinaphtho[b,g]
[1,8]naphthyridines (6–12)
4-Chloro-N-(naphth-1-yl)benzo[h]quinolin-2-amine (4,
0.002 mol) and the appropriate carboxylic acids (0.0025 mol)
were added to polyphosphoric acid (6 g of P2O5 in 3 mL of
H3PO4) and then heated. The reaction time, temperature main-
tained and various acids used for the synthesis of respective
product were mentioned in Table 2. After the completion of
the reaction, it was poured into ice water, neutralised with sat-
urated sodium bicarbonate solution to remove excess of car-
boxylic acids and extracted with ethyl acetate. It was then
puriﬁed by column chromatography using silica gel (eluted
with petroleum ether: ethyl acetate (93:7) to get the com-
pounds (6–12), which was then recrystallised using methanol.
8-(40-Methylphenyl)-dinaphtho[1,2-b:20,10-
g][1,8]naphthyridin-7(16H)-one (6)
Yellow spongy mass; Mp.: 185–187 C; Yield: 66%; IR (KBr,
cm1) mmax: 3144 (NH), 1680 (C‚O), 1592 (C‚N);
1H NMR
(500 MHz, CDCl3) (ppm) dH: 2.50 (s, 3H, C40ACH3), 7.35 (2d,
2H, C2
0 & C60AH), 7.54–8.34 (m, 12H, C2AC5, C9AC13, C30,
C5
0AH & C16ANH), 8.96 (d, 1H, J = 8.50 Hz, C6AH), 9.29
(dd, 1H Jo = 8.00 Hz, Jm = 2.00 Hz, C1AH), 9.64 (d, 1H,
J= 8.50 Hz, C14AH);
13C NMR (125 MHz, CDCl3) (ppm)
dC: 22.73, 119.51, 121.25, 121.91, 122.40, 123.95, 125.52,
126.73, 126.89, 127.05, 127.33, 127.64, 127.87, 127.98, 128.07,
128.58(2C), 128.92(2C), 129.62, 130.75, 131.41, 132.49,
133.56, 135.12, 136.27, 139.53, 142.31, 147.89, 155.93, 178.79;
Anal. Calcd. for C31H20N2O (436): C, 85.30; H, 4.62; N,
6.42%; Found: C, 85.34; H, 4.58; N, 6.35%.
8-Methyldinaphtho[1,2-b:20,10-g][1,8]naphthyridin-7(16H)-
one (7)
Yellow prisms; Mp.: 154–156 C; Yield: 43%; IR (KBr, cm1)
mmax: 3295 (NH), 1640 (C‚O), 1554 (C‚N);
1H NMR
(500 MHz, CDCl3) (ppm) dH: 3.07 (s, 3H, C8ACH3), 7.43–
8.22 (m, 9H, C2AC5, C9AC13AH), 8.51(s, 1H, C16ANH),
9.01 (d, 1H, J = 8.00 Hz, C6AH), 9.31 (dd, 1H Jo = 8.50 Hz,
Jm = 1.50 Hz, C1AH), 9.63 (d, 1H, J= 9.00 Hz, C14AH);
13C
NMR (125 MHz, CDCl3) (ppm) dC: 29.85, 119.66, 121.17,
121.85, 122.53, 124.05, 125.63, 126.69, 126.99, 127.00, 127.13,
127.72, 127.86, 127.91, 128.21, 129.76, 131.29, 132.55, 133.87,
135.34, 139.49, 142.50, 147.58, 154.90, 179.11; Anal. Calcd.
for C25H16N2O (360): C, 83.31; H, 4.47; N, 7.77%; Found:
C, 83.36; H, 4.54; N, 7.70%.
8-(40-Methoxyphenyl)dinaphtho[1,2-b:20,10-
g][1,8]naphthyridin-7(16H)-one (8)
Yellow solid; Mp.: 191–193 C; Yield: 69%; IR (KBr, cm1)
mmax: 3166 (NH), 1626 (C‚O), 1567 (C‚N);
1H NMR
(500 MHz, CDCl3) (ppm) dH: 4.05 (s, 3H, C40ACH3), 7.26
(2d, 2H, C2
0 & C60AH), 7.38 (2d, 2H, C30 & C50AH), 7.40–
8.09 (m, 9H, C2AC5, C9AC13AH), 8.22 (s, 1H, C16ANH),
8.86 (d, 1H, J = 7.50 Hz, C6AH), 9.30 (d, 1H J= 8.00 Hz,
C1AH), 9.61 (d, 1H, J= 8.50 Hz, C14AH);
13C NMR
(125 MHz, DMSO-d6) (ppm) dC: 53.86, 118.96, 121.16,121.86, 122.27, 124.15, 125.64, 126.68, 126.78, 127.15, 127.41,
127.51, 127.79, 127.90, 128.11, 128.46(2C), 129.09 (2C),
129.70, 130.64, 131.36, 132.50, 133.30, 135.30, 136.31, 139.42,
142.27, 148.90, 155.70, 178.49; Anal. Calcd. for C31H20N2O2
(452): C, 82.28; H, 4.45; N, 6.19%; Found: C, 82.34; H,
4.51; N, 6.14%.8-(40-Chlorophenyl)dinaphtho[1,2-b:20,10-g][1,8]naphthyridin-
7(16H)-one (9)
Yellow solid; Mp.: 176–178 C; Yield: 71%; IR (KBr, cm1)
mmax: 3210 (NH), 1639 (C‚O), 1598 (C‚N);
1H NMR
(500 MHz, CDCl3) (ppm) dH: 7.40 (2d, 2H, C20 & C60AH),
7.55–8.54 (m, 12H, C2AC5, C9AC13, C30, C50AH &
C16ANH), 8.85 (d, 1H, J = 8.00 Hz, C6AH), 9.22 (dd, 1H
Jo = 8.00 Hz, Jm = 2.00 Hz, C1AH), 9.59 (d, 1H,
J= 8.50 Hz, C14AH);
13C NMR (125 MHz, DMSO-d6)
(ppm) dC: 118.99, 121.09, 121.76, 122.39, 123.88, 125.67,
126.81, 126.90, 127.20, 127.29, 127.59, 127.80, 127.94, 128.21,
128.33(2C), 129.87, 130.01(2C), 130.59, 131.50, 132.38,
133.50, 135.23, 136.18, 139.61, 142.40, 147.64, 153.76, 180.06;
Anal. Calcd. for C30H17ClN2O (456): C, 78.86; H, 3.75; N,
6.13%; Found: C, 78.81; H, 3.82; N, 6.07%%.
8-(40-Nitrophenyl)dinaphtho[1,2-b:20,10-g][1,8]naphthyridin-
7(16H)-one (10)
Dark yellow solid; Mp.: 167–169 C; Yield: 61%; IR (KBr,
cm1) mmax: 3131 (NH), 1641 (C‚O), 1599 (C‚N);
1H
NMR (500 MHz, CDCl3) (ppm) dH: 7.34–8.36 (m, 13H,
C2AC5, C9AC13, C20, C60, C30 & C50AH), 8.50 (s, IH,
C16ANH), 8.91 (d, 1H, J = 7.50 Hz, C6AH), 9.34 (dd,
1H, Jo = 8.50 Hz, Jm = 1.50 Hz, C1AH), 9.65 (d, 1H,
J= 9.00 Hz, C14AH);
13C NMR (125 MHz, CDCl3)
(ppm) dC: 119.19, 121.36, 121.84, 122.61, 123.87, 125.73,
126.81, 126.93, 127.17, 127.41, 127.59, 127.76, 127.88,
128.11, 128.49(2C), 129.77, 130.10(2C), 130.65, 131.39,
132.33, 133.65, 134.98, 136.47, 139.62, 143.86, 148.78,
154.57, 180.11; Anal. Calcd. for C30H17N3O3 (467): C,




Yellow solid; Mp.: 183–185 C; Yield: 57%; IR (KBr, cm1)
mmax: 3243 (NH), 1655 (C‚O), 1590 & 1521 (C‚N);
1H
NMR (500 MHz, CDCl3) (ppm) dH: 7.40 (t, 1H,
J = 5.00 Hz C5
0AH), 7.44–8.29 (m, 9H, C2AC5, C9AC13AH),
8.32 (d, 1H, J= 5.50 Hz, C4
0AH), 8.40 (s, 1H, C16ANH),
8.51 (d, 1H, J= 4.50 Hz, C6
0AH), 8.86 (s, 1H, C20AH),
8.93 (d, 1H, J = 8.50 Hz, C6AH), 9.27 (dd, 1H Jo = 9.00 Hz,
Jm = 2.00 Hz, C1AH), 9.58 (d, 1H, J= 8.00 Hz, C14AH);
13C NMR (125 MHz, CDCl3) (ppm) dC: 117.55, 120.97,
121.75, 123.13, 124.67, 125.82, 125.99, 126.09, 126.77,
127.05, 127.43, 127.58, 127.81, 128.11, 128.74, 129.90,
130.19, 131.46, 132.67, 133.39, 134.70, 136.54, 138.03,
143.70, 146.75, 147.58, 149.29, 155.14, 178.88; Anal. Calcd.
for C29H17N3O (423): C, 82.25; H, 4.05; N, 9.92%; Found:
C, 82.30; H, 4.01; N, 9.88%.
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7(16H)-one (12)
Yellow solid; Mp.: 177–179 C; Yield: 41%; IR (KBr, cm1)
mmax: 3209 (NH), 1645 (C‚O), 1592 & 1528 (C‚N);
1H
NMR (500 MHz, CDCl3) (ppm) dH: 7.19 (t, 1H, J = 5.00 Hz
C4
0AH), 7.31–8.18 (m, 11H, C2AC5, C9AC13, C30 & C50AH),
8.38(s, 1H, C16ANH), 9.03 (d, 1H, J = 7.50 Hz, C6AH),
9.28 (dd, 1H, Jo = 8.00 Hz, Jm = 2.50 Hz, C1AH), 9.52 (d,
1H, J= 8.50 Hz, C14AH); Anal. Calcd. for C28H16N2OS
(428): C, 78.48; H, 3.76; N, 6.54; S, 7.48%; Found: C, 78.53;
H, 3.80; N, 6.49; S, 7.51%.
General procedure for the synthesis of
dinaphtho[b,h][1,6]naphthyridines (13–20)
A mixture of N2,N4-di(naphth-1-yl)benzo[h]quinoline-2,4-dia-
mine (5, 0.002 mol) and appropriate carboxylic acids
(0.0025 mol) were added to polyphosphoric acid (6 g of P2O5
in 3 mL of H3PO4). The reaction time, temperature maintained
and various acids used for synthesis of the respective product
were mentioned in Table 2. The reaction was monitored by
TLC. After the completion of the reaction, it was poured into
ice water, neutralised with saturated solution of sodium bicar-
bonate to remove excess of carboxylic acids, extractedwith ethyl
acetate, puriﬁed by column chromatography using silica gel and
product was eluted with petroleum ether:ethyl acetate (97:3)
mixture to get (13–20) which was recrystallised using methanol.
N-(Naphth-100-yl)-7-(40-methylphenyl)-dinaphtho[1,2-b:10,20-
h][1,6]naphthyridin-6-amine (13)
Orange prisms; Mp.: 262–264 C; Yield: 75%; IR (KBr, cm1)
mmax: 3048 (NH), 1655, 1601 (C‚N);
1H NMR (500 MHz,
CDCl3) (ppm) dH: 2.48 (s, 3H, C40ACH3), 7.25–8.32 (m,
20H, C2, C3, C8, C9, C10, C11, C12, C16, C2
0, C30, C50, C60,
C2
00AC800 and C6ANH), 8.87 (d, 1H, C1AH, J = 8.00 Hz),
8.95 (d, 1H, C16AH, J = 7.50 Hz), 9.27 (d, 1H, C4AH
J = 8.00 Hz), 9.51 (d, 1H, C15AH, J = 8.00 Hz), 9.87 (d,
1H, C13AH, J = 7.50 Hz);
13C NMR (125 MHz, CDCl3)
(ppm) dC: 22.56 (C40ACH3), 114.27, 119.33, 120.57, 121.07,
121.86, 122.11, 122.96, 123.41, 124.25, 125.18, 126.01, 126.59,
126.68, 126.92, 127.22, 127.34, 127.41, 127.50, 127.63, 127.77,
127.89, 128.35 (2C), 128.90 (2C), 129.06, 129.42, 130.24,
130.86, 131.57, 132.69, 133.48, 134.03, 134.85, 136.13, 140.72,
144.55, 147.71, 149.90, 158.07; MS (EI) m/z (%) 561 (M+,
75); Anal. Calcd. for C41H27N3 (561): C, 87.67; H, 4.85; N,
7.48%; Found: C, 87.61; H, 4.90; N, 7.51%.
7-Methyl-N-(naphth-100-yl)dinaphtho[1,2-b:10,20-
h][1,6]naphthyridin-6-amine (15)
Orange solid; Mp.: 241–243 C; Yield: 57%; IR (KBr, cm1)
mmax: 3098 (NH), 1635, 1611 (C‚N);
1H NMR (500 MHz,
CDCl3) (ppm) dH: 3.26 (s, 3H, C7ACH3), 7.39–8.29 (m, 15H,
C2, C3, C8, C9, C10, C11, C12, C2
00AC800 and C6ANH), 8.76
(d, 1H, C1AH, J = 8.00 Hz), 8.95 (d, 1H, C16AH,
J = 7.50 Hz), 9.30 (d, 1H, C4AH J = 8.00 Hz), 9.55 (d, 1H,
C15AH, J = 8.00 Hz), 9.85 (d, 1H, C13AH, J = 7.50 Hz);
13C NMR (125 MHz, CDCl3) (ppm) dC: 26.6 (C7ACH3),113.89, 118.61, 120.09, 121.11, 121.72, 122.26, 122.73, 123.50,
124.39, 125.24, 126.11, 126.47, 126.59, 126.89, 127.14, 127.26,
127.31, 127.60, 127.71, 127.82, 127.99, 129.00, 129.37, 130.51,
131.66, 132.73, 133.53, 134.16, 135.24, 141.03, 144.62, 147.31,
148.76, 157.12; MS (EI) m/z (%) 485 (M+, 79); Anal. Calcd.
for C35H23N3 (485): C, 86.57; H, 4.77; N, 8.65%; Found: C,
86.61; H, 4.84; N, 8.59%.
7-(40-Methoxyphenyl)-N-(naphth-100-yl)dinaphtho[1,2-b:10,20-
h][1,6]naphthyridin-6-amine (16)
Orange prisms; Mp.: 271–273 C; Yield: 61%; IR (KBr, cm1)
mmax: 3123 (NH), 1617, 1581(C‚N);
1H NMR (500 MHz,
CDCl3) (ppm) dH: 3.81 (s, 3H, C40AOCH3), 7.27–8.23 (m,
19H, C2, C3, C8, C9, C10, C11, C12, C2
0, C30, C50, C60, C200AC800
and C6ANH), 8.85 (d, 1H, C1AH, J = 8.50 Hz), 8.98 (d, 1H,
C16AH, J= 8.00 Hz), 9.33 (d, 1H, C4AH J = 8.00 Hz), 9.49
(d, 1H, C15AH, J = 8.50 Hz), 9.90 (d, 1H, C13AH,
J = 8.00 Hz); 13C NMR (125 MHz, CDCl3) (ppm) dC: 55.99
(C4
0AOCH3), 113.94, 119.45, 120.66, 121.12, 121.70, 122.02,
122.76, 123.53, 124.44, 125.26, 126.18, 126.47, 126.71, 126.88,
127.30, 127.42, 127.53, 127.64, 127.76, 127.85, 127.91, 128.45
(2C), 128.86 (2C), 129.19, 129.50, 130.42, 130.77, 131.65,
132.52, 133.64, 134.41, 134.67, 135.28, 141.25, 143.48, 146.17,
149.56, 157.71; MS (EI) m/z (%) 577 (M+, 91); Anal. Calcd.
for C41H27N3O (577): C, 85.25; H, 4.71; N, 7.27%; Found:
C, 85.31; H, 4.77; N, 7.20%.
7-(40-Chlorophenyl)-N-(naphth-100-yl)dinaphtho[1,2-b:10,20-
h][1,6]naphthyridin-6-amine (17)
Orange prisms; Mp.: 255–257 C; Yield: 69%; IR (KBr,
cm1) mmax: 3134(NH), 1609, 1590(C‚N);
1H NMR
(500 MHz, CDCl3) (ppm) dH: 7.30–8.13 (m, 19H, C2, C3, C8,
C9, C10, C11, C12, C2
0, C30, C50, C60, C200AC800 and C6ANH),
8.71 (d, 1H, C1AH, J= 7.50 Hz), 8.96 (d, 1H, C16AH,
J = 8.50 Hz), 9.38 (d, 1H, C4AH J = 9.00 Hz), 9.59 (d, 1H,
C15AH, J = 8.00 Hz), 9.87 (d, 1H, C13AH, J = 8.50 Hz);
13C
NMR (125 MHz, CDCl3) (ppm) dC: 114.32, 118.90, 120.46,
121.00, 121.51, 122.31, 122.78, 123.55, 124.39, 125.30, 126.14,
126.60, 126.76, 126.81, 127.19, 127.28, 127.37, 127.47, 127.56,
127.66, 127.75, 128.40 (2C), 128.87 (2C), 129.19, 129.37,
130.46, 130.68, 131.94, 132.75, 133.71, 134.42, 134.73, 135.28,
140.44, 145.16, 148.54, 149.70, 158.24; MS (EI) m/z (%) 581
(M+, 81), 583 (M+2, 31); Anal. Calcd. For C40H24ClN3




Pale orange prisms; Mp.: 251–253 C; Yield: 57%; IR (KBr,
cm1) mmax: 3201, 1644, 1571;
1H NMR (500 MHz, CDCl3)
(ppm) dH: 7.32–8.27 (m, 19H, C2, C3, C8, C9, C10, C11, C12,
C2
0, C30, C50, C60, C200AC800 and C6ANH), 8.84 (d, 1H,
C1AH, J = 8.00 Hz), 8.96 (d, 1H, C16AH, J = 9.00 Hz),
9.31 (d, 1H, C4AH J = 8.00 Hz), 9.58 (d, 1H, C15AH,
J = 8.50 Hz), 9.91 (d, 1H, C13AH, J = 8.00 Hz);
13C NMR
(125 MHz, CDCl3) (ppm) dC: 113.94, 118.80, 120.76, 121.33,
121.90, 122.27, 122.81, 123.65, 124.84, 125.37, 126.25, 126.48,












Scheme 1 Synthesis of 2,4-dichlorobenzo[h]quinoline (3).
Synthesis of [1,6] and [1,8]dinaphthonaphthyridines 635127.99, 128.51 (2C), 128.99 (2C), 129.13, 129.59, 130.42,
130.68, 131.77, 132.36, 133.84, 134.22, 134.49, 135.30, 140.57,
143.67, 146.85, 148.70, 159.19; MS (EI) m/z (%) 592 (M+,
90); Anal. Calcd. for C40H24N4O2 (592): C, 81.07; H, 4.08;
N, 9.45%; Found: C, 81.14; H, 4.03; N, 9.51%.
N-(Naphth-100-yl)-7-(pyridin-30-yl)dinaphtho[1,2-b:10,20-
h][1,6]naphthyridin-6-amine (19)
Orange solid; Mp.: 233–235 C; Yield: 41%; IR (KBr, cm1)
mmax: 3086 (NH), 1625, 1603 (C‚N);
1H NMR (500 MHz,
CDCl3) (ppm) dH: 7.39–8.29 (m, 16H, C2, C3, C8, C9, C10,
C11, C12, C5
0, C200AC800 and C6ANH), 8.41 (d, 1H, C40AH,
J = 4.50 Hz), 8.59 (d, 1H, C6
0AH, J = 5.50 Hz), 8.77 (s, 1H,
C2
0AH), 8.81 (d, 1H, C1AH, J = 8.50 Hz), 8.99 (d, 1H,
C16AH, J = 7.50 Hz), 9.27 (d, 1H, C4AH J = 8.50 Hz), 9.49
(d, 1H, C15AH, J = 9.00 Hz), 9.78 (d, 1H, C13AH,
J = 7.50 Hz); 13C NMR (125 MHz, CDCl3) (ppm) dC:
114.65, 117.43, 129.99, 120.82, 121.09, 122.04, 122.59, 123.00,
124.71, 125.69, 126.26, 126.49, 126.60, 126.98, 127.09, 127.31,
127.42, 127.56, 127.76, 127.89, 127.95, 128.34, 129.13, 129.59,
130.66, 131.73, 132.65, 133.38, 133.72, 134.27, 135.54, 136.09,
141.36, 144.71, 145.54, 147.37, 148.82, 149.47, 156.90; MS
(EI) m/z (%) 548 (M+, 100); Anal. Calcd. for C39H24N4




Orange solid; Mp.: 228–230 C; Yield: 33%; IR (KBr, cm1)
mmax: 3077 (NH), 1643, 1621 (C‚N);
1H NMR (500 MHz,
CDCl3) (ppm) dH: 7.22 (t, 1H, C40AH, J = 5.50 Hz), 7.32–
8.34 (m, 18H, C2, C3, C8, C9, C10, C11, C12, C3
0, C50, C200AC800
and C6ANH), 8.46 (d, 1H, C40AH, J = 4.50 Hz), 8.66 (d, 1H,
C6
0AH, J = 5.50 Hz), 8.80 (s, 1H, C20AH), 8.92 (d, 1H, C1AH,
J = 8.50 Hz), 9.17 (d, 1H, C16AH, J = 7.50 Hz), 9.31 (d, 1H,Table 1 The reaction conditions and the yields of the two compou
Entry Catalysta Solvent T (C)
1 – MeOH Reﬂux
2 CuI MeOH Reﬂux
3 – Ethanol Reﬂux
4 CuI Ethanol Reﬂux
5 CuI DMF Reﬂux
6 CuI DMSO 120
7 CuI DMSO 120
8 – DMSO 120
a 10 mol% of catalyst.C4AH J = 8.50 Hz), 9.54 (d, 1H, C15AH, J = 9.00 Hz), 9.74
(d, 1H, C13AH, J = 7.50 Hz); MS (EI) m/z (%) 553 (M
+,
100); Anal. Calcd. for C38H23N3S (553): C, 82.43; H, 4.19;
N, 7.59; S, 5.79%; Found: C, 82.38; H, 4.21; N, 7.60; S, 5.81%.
Results and discussion
Synthesis of dinaphtho[b,g][1,8]naphthyridines
The required precursor for the synthesis of substituted angular
and linear dinaphthonaphthyridines, 2,4-dic-
hlorobenzo[h]quinoline (3) was obtained from naphth-1-yla-
mine 1 and malonic acid (2) under reﬂux in POCl3 for 8 h as
depicted in Scheme 1.
Compound 3 was then reacted with naphth-1-ylamine 1 in
the presence of CuI catalyst, afforded 4 and 5. The reaction
conditions and the yields of the two compounds obtained were
depicted in Table 1. In the absence of catalyst the reaction in
methanol gave 31% of compound 4 and 28% of compound
5 in 8 h (entry 1 in Table 1), whereas by using 10 mol% of
CuI as catalyst reduces the reaction time from 8 h to 2 h and
increased the yield of the products marginally (entry 2 in Ta-
ble 1). When the solvent was changed from methanol to etha-
nol, we obtained the compounds 4 & 5 in 40% and 38%
respectively in 2 h using 10 mol% of CuI (entry 4 in Table 1).
To our surprise, when the reaction was performed in DMSO as
solvent (using 10 mol% of CuI) within 0.5 h we obtained 57%
and 31% of compounds 4 & 5 (entry 6 in Table 1). Interest-
ingly, when the reaction was allowed for another half an hour
(entry 7 in Table 1) product 5 was obtained as a major product
(51%) along with 45% yield of compound 4. It is noteworthy
to mention here that, reaction in DMSO in the absence of cat-
alyst, (entry 8 in Table 1) even after 8 h resulted in 30% and
27% of the compounds 4 and 5. In the presence of catalyst
the reaction time came down from 8 h to 0.5 h with the com-
bined (4+ 5) yield of 96%. But in the absence of catalyst,
the combined yield of 4 & 5 was 57%. Reduction of time
and substantial increase in yield clearly indicate the effect of
CuI catalyst in the reaction.
It is documented that in SNAr, the reaction rate gets accel-
erated by activating the amine through hydrogen bonding
when the reaction was performed in polar aprotic solvent like
DMSO [29,30]. Hence it is anticipated that the second step
(I to II in Scheme 3) was accelerated in the presence of DMSO
and hence the possible explanation for the increased yield
when the reaction was performed in DMSO/CuI (entry 7 in
Table 1). The present ﬁnding showed that the combinationnds 4 and 5.










Table 2 Synthesis and reaction conditions of compound 6–20.
Compounds Acid Productsa t (h) T (C)
6 3.5 230
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Table 2 (Continued)




15 CH3COOH 1 rt
16 1 rt
(continued on next page)
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Table 2 (Continued)





rt – Room temperature.
a The products were characterised by IR, NMR, MASS and elemental analysis (refer experimental section).
638 K. Prabha and K.J. Rajendra Prasadof DMSO and CuI turns out to be the best among the combi-
nation screened.
IR spectrum of the ﬁrst eluted product showed stretching
vibrations at 3066 cm1 and 1636 cm1 due to NH andC‚N groups. In its 1H NMR spectrum, C4ANH appeared
as a broad singlet at d 7.02, C3AH appeared as a singlet at d
7.17 and all the aromatic protons appeared between the region





























Scheme 2 Synthesis of benzoquinolin-amines (4) and (5).
Synthesis of [1,6] and [1,8]dinaphthonaphthyridines 639twenty-three carbons and its mass spectrum showed the molec-
ular ion peak at m/z 354. On the basis of the reactivity of
chlorine atom in the 2 and 4 positions of the 2,4-dichloroquin-
oline [31,32], the ﬁrst compound was assigned as 2-substituted
product namely, 4-chloro-N-(naphth-1-yl)benzo[h]quinolin-2-
amine (4).
The second product showed stretching frequencies at
3136 cm1, 3054 cm1 and 1629 cm1 in the IR spectrum
due to two NH and C‚N functional groups. In its 1H
NMR spectrum C3AH appeared as a singlet at d 6.51, all
the aromatic protons appeared between the region d 7.01
and 9.38. Three broad singlets appeared at d 10.74, 11.45
and 14.13 were assigned for C4ANH, C2ANH and N1AH,


























Scheme 3 Mechanism for the formation of compound (4).33 carbons. All the aforesaid data attest the obtained product
as 2,4-disubstituted product, namely, N2,N4-di(naphth-1-
yl)benzo[h]quinoline-2,4-diamine (5) which was found to be
in resonance with the two imino forms on the basis of its IR
and 1H NMR spectra (Scheme 2).
The proposed plausible mechanism for the formation of
compound 4 is as follows. The ﬁrst step involves the oxidative
addition of compound 3 with CuI to form the intermediate I.
Then the elimination of H and Cl elements between the inter-
mediate I and compound 1 leads to the formation of interme-
diate II. This further undergoes reductive elimination to give
compound 4 and regenerated the catalyst. Compound 4 under-
goes a similar catalytic cycle to afford compound 5 (Scheme 3).
In order to get the target linear dinaphthonaphthyridine, 4-
chloro-N-(naphth-1-yl)benzo[h] quinolin-2-amine (4) was re-
acted with p-toluic acid in the presence of poly phosphoric acid
at 230 C which afforded a single product. The IR spectrum
showed stretching frequencies at 3144 cm1, 1680 cm1 and
1592 cm1 revealed the presence of NH, C‚O and C‚N
functional groups respectively. In its 1H NMR spectrum a sin-
glet at d 2.50 was due to the presence of C40ACH3 proton. Rest
of the aromatic protons resonated in the region between d 7.35
and 9.64 including C16ANH. Its
13C NMR spectrum showed
the peak at d 178.79 due to the presence of C‚O group.
The molecular formula of the product was found to be
C31H20N2O calculated from elemental analysis. From the
aforementioned spectral and analytical information, the






























Scheme 5 Synthesis of dinaphtho[b,h][1,6]naphthyridine (13).
640 K. Prabha and K.J. Rajendra Prasadphenyl)-dinaphtho[1,2-b:20,10-g][1,8]naphthyridin-7(16H)-one (6)
(Scheme 4).
To explore the generality of the reaction, wehave also tried the
same reactionwith other carboxylic acids like acetic acid, p-meth-
oxy benzoic acid, p-chloro benzoic acid, p-nitro benzoic acid, pyr-
idine-3-carboxylic acid and thiophen-2-carboxylic acid to get the
corresponding linear 8-substituted dinaphtho[1,2-b:20,10-
g][1,8]naphthyridin-7(16H)-one (7–12) Table 2. The structures
of all compounds were conﬁrmed by elemental and spectral anal-
ysis (refer experimental section and supporting data).Synthesis of dinaphtho[b,h][1,6]naphthyridines
Next, in order to construct angular naphthyridines N2,N4-
di(naphth-1-yl) benzo[h]quinoline-2,4-diamine (5) was reacted
with p-toluic acid in the presence of poly phosphoric acid as
catalyst at room temperature (stirring for half an hour). The
IR spectrum showed stretching frequencies at 3048 cm1,
1655 cm1 and 1601 cm1 which were due to the presence of
NH and two C‚N functional groups respectively. In its 1H
NMR spectrum, methyl protons appeared as a singlet at d
2.48 for C4
0ACH3. All the aromatic protons appeared between
the region d 7.25 and 8.95 except for C4AH, C15AH and
C13AH which appeared as three doublets at d 9.27
(J= 8.00 Hz, J= 1.50 Hz), 9.51 (J= 8.00 Hz) and 9.87
(J= 7.50 Hz) respectively. The 13C NMR spectrum showed
the presence of 41 carbons. All the spectral data revealed the
formation of the compound 13. Here the chance of getting
the linear naphthyridine 14 has not been observed and the only
formed product was assigned as the thermodynamically more
stable angular isomer namely, N-(naphth-100-yl)-7-(40-methyl-
phenyl)-dinaphtho[1,2-b:10,20-h][1,6]naphthyridin-6-amine 13,
on the basis of its higher melting point and literature data
[33,34] (Scheme 5).
Encouraged by these results, this procedure was then fur-
ther evaluated for its scope and general applicability. A sim-
ilar set of reaction was extended to 5 with acetic acid, p-
methoxy benzoic acid, p-chloro benzoic acid, p-nitro benzoic,
pyridine-3-carboxylic acid and thiophen-2-carboxylic acid in
the presence of polyphosphoric acid to afford the respective7-substituted dinaphtho[1,2-b:10,20-h][1,6]naphthyridin-6-
amine (15–20) as a single compound (Table 2). Very interest-
ingly electron withdrawing group substituted benzoic acid
undergoes cyclisation in shorter reaction time when compared
to electron donating group substituted benzoic acid. The
structures of all compounds were conﬁrmed by elemental
and spectral analysis (refer experimental section and support-
ing data).
Conclusions
A useful method for the synthesis of intermediates 4 and 5
using 10 mol% of CuI catalyst was developed. Both the inter-
mediates undergo facile cyclisation under poly phosphoric acid
condition with aliphatic and various aromatic/heteroaromatic
carboxylic acids afforded angular and linear dina-
phthonaphthyridines. This method has the potential to create
new libraries of substituted dinaphthonaphthyridines which
may ﬁnd applications in medicinal chemistry.
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